- Home
- / TalkMed Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TalkMed Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.5
2024-10-29
Market Capitalization
$604.1 M
2024-10-29
Revenue
$78.2 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| SGD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 61.3M | 75.9M | 62.1M | 60.7M | 76.6M | 83.8M | 78.2M |
| Gross profit | 61.4M | 76.0M | 64.3M | 62.4M | 76.9M | 84.0M | 81.6M |
| Gross profit margin, % | 100.1% | 103.5% | 102.7% | 100.4% | 100.2% | 104.3% | |
| Operating expense total | 26.8M | 31.1M | 31.7M | 31.5M | 35.2M | 42.2M | 42.9M |
| Depreciation and amortization | 376.0K | 3.4M | 6.9M | 2.5M | 2.5M | 2.8M | 3.2M |
| EBITDA | 33.4M | 43.9M | 31.5M | 29.8M | 39.5M | 40.3M | 50.3M |
| EBITDA margin, % | 57.8% | 50.8% | 49.1% | 51.6% | 48.1% | 64.4% | |
| EBIT | 33.0M | 40.4M | 24.6M | 27.3M | 36.3M | 37.5M | 47.2M |
| EBIT margin, % | 53.3% | 39.6% | 45.0% | 47.4% | 44.8% | 60.3% | |
| Interest income | 982.0K | 1.3M | 709.0K | 333.0K | 883.0K | 2.6M | 2.6M |
| Interest expense | 394.0K | 523.0K | 391.0K | 346.0K | 356.0K | 275.0K | |
| Pre tax profit | 34.0M | 41.3M | 24.8M | 27.3M | 36.8M | 37.8M | 49.4M |
| Income tax expense | 6.8M | 8.5M | 6.3M | 5.9M | 7.9M | 8.5M | 7.0M |
| Net Income | 27.2M | 32.8M | 18.5M | 21.4M | 29.0M | 29.4M | 42.4M |